BJ
TTPH

BlackRock Japan’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

BlackRock Japan’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-368
Closed -$99K – 1345
2014
Q2 		$99K Sell
368
-23
-6% -$4.94K ﹤0.01% 935
2014
Q1 		$85K Sell
391
-519
-57% -$145K ﹤0.01% 1089
2013
Q4 		$246K Buy
910
+24
+3% +$5.72K ﹤0.01% 881
2013
Q3 		$202K Buy
886
+373
+73% +$65.2K ﹤0.01% 894
2013
Q2 		$72K Buy
+513
New +$81.2K ﹤0.01% 1025

Other funds holding TTPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return

BlackRock Japan's TTPH Position: Q3 2014 in Review

BlackRock Japan sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2014, closing a stake of 368 shares — an estimated $99K sold.

BlackRock Japan first reported a position in TTPH in Q2 2013 and held it in 5 quarters. The position peaked at $246K in Q4 2013. 73 funds tracked by Wall St. Rank hold TTPH as of Q3 2014.

  • BlackRock Japan reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
  • BlackRock Japan sold 368 Tetraphase Pharmaceuticals, Inc. shares in Q3 2014, an estimated $99K.
  • BlackRock Japan first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 5 quarters.
  • BlackRock Japan's Tetraphase Pharmaceuticals, Inc. position peaked at $246K in Q4 2013.
  • 73 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2014.

Based on BlackRock Japan's 13F filing for Q3 2014, filed 29 Oct 2014.